SM
AMGN icon

Sabby Management’s Amgen AMGN Stock Holding History

Sabby Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-798
Closed -$13.1M – 219
2017
Q1 		$13.1M Buy
798
+497
+165% +$82.6K 0.71% 25
2016
Q4 		$4.4M Buy
+301
New +$45.3K 0.26% 59
2015
Q1 		– Sell
-580
Closed -$9.24K – 292
2014
Q4 		$9.24K Sell
580
-523
-47% -$81.5K 0.29% 41
2014
Q3 		$15.5K Buy
+1,103
New +$144K 0.59% 30

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Sabby Management's AMGN Position: Q2 2017 in Review

Sabby Management sold out of Amgen (AMGN) in Q2 2017, closing a stake of 37,104 shares — an estimated $6.09M sold.

Sabby Management first reported a position in AMGN in Q1 2014 and held it in 7 quarters. The position peaked at $37M in Q4 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Sabby Management reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Sabby Management sold 37,104 Amgen shares in Q2 2017, an estimated $6.09M.
  • Sabby Management first reported a position in Amgen in Q1 2014 and held it in 7 quarters.
  • Sabby Management's Amgen position peaked at $37M in Q4 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.